Finance | Nordic Life Science Insight

SAGA awarded SEK 4.7 million Vinnova grant from Swelife

SmiLe Incubator

November 26, 2018

SmiLe company Saga Diagnostics has been chosen following tough competition to be awarded a grant through Swelife’s “Project for better health, step 2” and will receive SEK 4.7 million. In addition to being a member of SmiLe Incubator, Saga is included in LU Holding’s portfolio of companies. Of the 22 projects that were evaluated, only eight receive funding and half of them come from Lund.

Finance

Sinntaxis secures Horizon 2020 grant to prepare for phase II trial in stroke recovery

SmiLe Incubator

November 26, 2018

Sinntaxis in Lund has been awarded SEK 500,000 under the SME instrument phase 1 program within the EU Horizon 2020 framework. The grant money will be used to advance the business plan and the regulatory work to initiate a phase II clinical trial in stroke recovery.

Finance

AbbVie Donates $55 Million to Three Education Nonprofits Supporting Underserved Youth in Chicago & Across America

AbbVie

November 20, 2018

‍Donations include $30 million to Communities In Schools, $10 million to City Year and $15 million to University of Chicago Education Lab. The contributions will significantly expand and strengthen programs to provide vulnerable children across the country with academic, social and emotional support to help them achieve their full potential.

Finance

Swedish Research Council gives In2cure project SEK 950,000 and highest grades

SmiLe Incubator

November 15, 2018

In2cure’s founder has received SEK 950,000 from the Swedish Research Council for development of the drug candidate BioC, which will be used to promote wound healing. The In2cure project received consistently high scores in the Research Council’s assessment.

Finance

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2019 Annual General Meeting

InDex Pharmaceuticals

November 7, 2018

InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2019 Annual General Meeting, which will be held on Monday May 6, 2019. The responsibility of the Nomination Committee is to present to the 2019 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.

Finance

InDex Pharmaceuticals carries out a directed share issue of approximately SEK 37.5 million

InDex Pharmaceuticals

October 25, 2018

The board of directors of InDex Pharmaceuticals Holding AB (publ) (the “Company” or “InDex”) has, with support from the authorization granted by the annual general meeting on May 24, 2018, resolved on a directed share issue of 6,252,842 shares to a small group of investors.

Date

Title

Author

October 2, 2018

in2cure raises SEK 10 million